메뉴 건너뛰기
Reviews in Clinical Gerontology
Volumn 11, Issue 1, 2001, Pages 33-49
Parkinson's disease
Author keywords

[No Author keywords available]
Indexed keywords

AMANTADINE; APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; SELEGILINE; TOLCAPONE;
EID: 0034917748     PISSN: 09592598     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0959259801011145     Document Type: Article
Times cited : (8)
References (130)
  • 2
    • 0032611679 scopus 로고    scopus 로고
    • Interdisciplinary rehabilitation in Parkinson's disease
    • Stern GM, ed. Philadelphia: Lippincott Williams and Wilkins
    • (1999) Advances in Neurology , vol.80 , pp. 555-559
    • Iansek, R.1
  • 15
    • 0032604060 scopus 로고    scopus 로고
    • Clinicopathological heterogeniety and non-dopaminergic influences on behavior in Parkinson's disease
    • Stern GM ed. Philadelphia: Lippincott, Williams and Wilkins
    • (1999) Advances in Neurology , vol.80 , pp. 409-417
    • Sagar, H.J.1
  • 19
    • 0006164301 scopus 로고    scopus 로고
    • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
    • (1996) Neurology , vol.47 , pp. 1113-1124
    • McKeith, I.G.1    Galasko, D.2    Kosaka, K.3
  • 43
    • 15444338952 scopus 로고    scopus 로고
    • The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases
    • European Consortium on Genetic Susceptibility in Parkinson's Disease
    • (1998) Ann Neurol , vol.44 , pp. 270-273
    • Vaughan, J.1    Durr, A.2    Tassin, J.3
  • 46
  • 59
    • 0028291013 scopus 로고
    • Old-onset Parkinson's disease compared with young onset disease: Clinical differences and similarities
    • (1994) Acta Neurol Scand , vol.89 , pp. 258-261
    • Friedman, A.1
  • 61
    • 0023784368 scopus 로고
    • A comparison of clinical and pathological features of young and old onset Parkinson's disease
    • (1988) Neurology , vol.38 , pp. 1402-1406
    • Gibb, W.R.1    Lees, A.J.2
  • 62
    • 0034105156 scopus 로고    scopus 로고
    • Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications
    • (2000) Ann Neurol , vol.47 , Issue.SUPPL. 1 , pp. 122-130
    • Chase, T.N.1    Oh, J.D.2
  • 64
    • 0028985322 scopus 로고
    • Drug treatment of Parkinson's disease
    • (1995) BMJ , vol.310 , pp. 575-579
    • Quinn, N.P.1
  • 66
    • 0000152049 scopus 로고    scopus 로고
    • Somnolence as an adverse drug reaction of antiparkinsonian drugs: A meta analysis of published randomised controlled trials
    • (2000) Mov Disord , vol.15 , Issue.SUPPL. 3 , pp. 128
    • Ferreira, J.J.1    Pona, N.2    Costa, J.3
  • 69
    • 0001787497 scopus 로고    scopus 로고
    • A five-year double- blind study with cabergoline versus levodopa in the treatment of early Parkinson's disease
    • (1999) Parkinsonism Relat Disord , vol.5 , Issue.SUPPL.
    • Rinne, U.K.1
  • 71
    • 0024456653 scopus 로고
    • Effect of deprenyl on the progression of disability in early Parkinson's disease
    • (1989) N Eng J Med , vol.321 , pp. 1364-1371
  • 72
    • 0027530638 scopus 로고
    • Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
    • (1993) N Eng J Med , vol.328 , pp. 176-183
  • 74
    • 9044226896 scopus 로고    scopus 로고
    • Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa
    • (1996) Ann Neurol , vol.39 , pp. 37-45
  • 75
    • 9044227267 scopus 로고
    • Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild disease
    • (1995) BMJ , vol.311 , pp. 1602-1607
    • Lees, A.J.1
  • 76
    • 0032542955 scopus 로고    scopus 로고
    • Investigation by Parkinson's Disease Research Group of the United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early mild Parkinson's disease: Further results of a randomised trial and confidential enquiry
    • (1998) BMJ , vol.316 , pp. 1191-1196
    • Ben-Shlomo, Y.1    Churchyard, A.2    Head, J.3
  • 78
    • 0031893241 scopus 로고    scopus 로고
    • Mortality in DATATOP; a multicenter trial in early Parkinson's disease
    • (1998) Ann Neurol , vol.43 , pp. 318-325
  • 85
  • 88
    • 0030778373 scopus 로고    scopus 로고
    • Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients
    • (1997) Ann Neurol , vol.42 , pp. 747-755
  • 101
    • 0032806189 scopus 로고    scopus 로고
    • The importance of psychological symptoms in Parkinson's disease
    • (1999) Age Ageing , vol.28 , pp. 335-336
    • Caird, F.I.1
  • 106
    • 0032966748 scopus 로고    scopus 로고
    • The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropychological test
    • (1999) Age Ageing , vol.28 , pp. 39-43
    • Hobson, P.1    Meara, J.2
  • 109
    • 0032610780 scopus 로고    scopus 로고
    • The place of dementia in Parkinson's disease: A methodological saga
    • Stern GM ed. Philadelphia: Lippincott Williams and Wilkins
    • (1999) Advances in neurology , vol.80 , pp. 403-408
    • Mindham, R.H.S.1
  • 117
    • 0032966337 scopus 로고    scopus 로고
    • Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their carers in the community
    • (1999) Age Ageing , vol.28 , pp. 35-38
    • Meara, J.1    Mitchelmore, E.2    Hobson, P.3
  • 122
    • 0033594423 scopus 로고    scopus 로고
    • Dopaminomimetic psychosis in Parkinson's disease patients: Diagnosis
    • (1999) Neurology , vol.52 , Issue.SUPPL. 3
    • Wolters, E.C.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.